Project Grant R21EB035375
Award Date
9/20/24
Completion Date
9/19/26
Dollars Obligated
$366K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30332, USA
Similar Awards
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), provides $366,006.00 to Georgia Tech Research Corp to develop flexible piezo film intravascular ultrasound arrays on guidewires and catheters. The goal is to integrate intravascular ultrasound capability onto standard medical devices used for percutaneous coronary...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to develop nano-scale phase-changing contrast agents for high-resolution ultrasound imaging of adoptive cellular immunotherapies. The $490,381 award to The Pennsylvania State University will fund the creation of peptide nanoemulsions (NPEPs) that can be rapidly internalized by macrophages and generate echogenic bubbles for real-time, long-term...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $200,557 to North Carolina State University to develop and validate a novel duplex, dual-frequency capacitive micromachined ultrasonic transducer (CMUT) array system for high-contrast, high-resolution microvascular imaging. The specific objectives are to: 1) Design...
This $2,291,527 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program supports the development and validation of an ultrafast, bubble-specific ultrasound imaging system to monitor histotripsy, a noninvasive focused ultrasound therapy, for the treatment of renal cell carcinoma (RCC). The key objectives are to: 1) Integrate...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $2,278,167 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to the University of North Carolina at Chapel Hill (UNC-CH) and the California Institute of Technology (Caltech). The grant, effective August 20, 2024 through April 30, 2028, supports the development of non-invasive transcranial volumetric super-resolution...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $543,959 Project Grant (R01EB037129) to the Regents of the University of Michigan under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The goal of this 4-year grant is to develop a Transcranial Magnetic Resonance (MR) and Ultrasound (US) Guided Histotripsy (TCMR-USGHT) system for the non-invasive treatment of brain tumors. The proposed...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will develop a novel molecular imaging technology that combines positron emission tomography (PET) and ultrasound (US) imaging. The total funding for this award is $1,541,316.00 with a period of performance from September 1, 2024 to May 31, 2028. The key products to be delivered...
This $497,870 federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports the development of genetically-encoded molecular imaging techniques to non-invasively monitor and track genome-edited immune cells, such as CAR-T cells, in vivo. The project aims to engineer mammalian cells to express bacterial metallophore transport proteins that can bind radionuclide-labeled probes, enabling real-time PET imaging and tracking of the...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $348,373 Project Grant (CFDA 93.286: Discovery and Applied Research for Technological Innovations to Improve Human Health) to Central Michigan University (CMU) to develop a novel family of biosensors that can report and dynamically regulate changes in neuroinflammation within the brains of live animals. The key products to be delivered under this 2-year grant include: Developing and optimizing split...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $295,308 to Actoprobe LLC to develop and validate a novel class of scanning probe microscopy (SPM) probes. The goal is to dramatically improve the sensitivity and spatial resolution of scanning near-field optical microscopy (SNOM) and tip-enhanced Raman spectroscopy...